Australia markets closed

ScinoPharm Taiwan, Ltd. (1789.TW)

Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
28.80+0.45 (+1.59%)
At close: 01:30PM CST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
385,068
287,056
353,216
243,471
282,067
-
Depreciation & amortisation
464,692
461,167
439,465
381,532
393,197
-
Stock-based compensation
-
-
-
0
84
2,050
Change in working capital
-452,147
-489,073
-24,360
-94,320
254,346
-
Inventory
-301,072
-347,470
157,631
-81,361
-47,959
-
Other working capital
108,577
-53,589
523,747
188,503
763,216
-
Other non-cash items
-8,382
-17,571
-17,332
-30,437
-71,224
-
Net cash provided by operating activities
418,685
231,126
773,791
509,823
946,312
-
Cash flows from investing activities
Investments in property, plant and equipment
-310,108
-284,715
-250,044
-321,320
-183,096
-
Purchases of investments
-
0
-47,982
-348,913
-642,281
-
Sales/maturities of investments
51,070
51,132
44,149
595,768
1,062,731
-
Other investing activities
119
157
-32
4,252
4,231
-
Net cash used for investing activities
-258,783
-233,290
-253,618
-69,981
241,720
-
Net change in cash
-207,899
-353,185
213,788
25,973
749,970
-
Cash at beginning of period
4,433,725
4,294,709
4,080,921
4,054,948
3,304,978
-
Cash at end of period
4,226,850
3,941,524
4,294,709
4,080,921
4,054,948
-
Free cash flow
Operating cash flow
418,685
231,126
773,791
509,823
946,312
-
Capital expenditure
-310,108
-284,715
-250,044
-321,320
-183,096
-
Free cash flow
108,577
-53,589
523,747
188,503
763,216
-